Exploring How Sequencing and Omics are Shaping Disease Research
In this symposium, an expert panel will discuss how sequencing and omics technologies enable unprecedented exploration of health and disease, from genetic disorders to cancer.
Exploring How Sequencing and Omics are Shaping Disease Research
Exploring How Sequencing and Omics are Shaping Disease Research
In this symposium, an expert panel will discuss how sequencing and omics technologies enable unprecedented exploration of health and disease, from genetic disorders to cancer.
In this symposium, an expert panel will discuss how sequencing and omics technologies enable unprecedented exploration of health and disease, from genetic disorders to cancer.
This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan.
Calculating the polygenic risk scores of ancient humans such as Ötzi the iceman helps researchers understand the genetic predisposition to cardiovascular disease.
Ryan Layer, The Conversation | May 27, 2022 | 5 min read
Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.
Aleksei Aksimentiev and Stefan Howorka discuss challenges in amino acid sensing with nanopores and approaches to design efficient protein sequencing technology.